Takeda Pharmaceuticals dengue vaccine assumes significance since the first vaccine ever licensed for dengue, developed by French drugmaker Sanofi Pasteur, met with failure as it only helped people who had been previously infected with the virus.
Takeda Accelerates Access to its Dengue Vaccine Through Make in India Manufacturing Partnership with Biological E bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.
Get latest articles and stories on Business at LatestLY. Singapore, February 27: Takeda (TSE:4502/NYSE:TAK) today announced a strategic partnership with Biological E. Limited, a leading vaccines and biologics company in India, to manufacture Takeda's dengue vaccine, TAK-003. The partnership marks a crucial step in the fight against the global public health threat of dengue fever, aligning with the disease-specific target set by the World Health Organization (WHO) to achieve zero case-fatality rate due to dengue by 2030[i]. Business News | Takeda Accelerates Access to Its Dengue Vaccine Through 'Make in India' Manufacturing Partnership with Biological E..